Romel Somwar

10PUBLICATIONS
98CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.

Daniel E Gracilla, Shruti Menon, Marcus R Breese

|Jan 16, 2026
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236.

Alexander J Pfeil, Tom Zhang, Ryan Cheng

|May 31, 2025
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Rocky Shi, Dylan A Farnsworth, Christopher A Febres-Aldana

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Sep 30, 2024
Preclinical evaluation of targeted therapies for central nervous system metastases.

Alexander J Pfeil, Joshua D Hale, Tiger S Zhang

|Aug 09, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Tom Zhang, Christopher A Febres-Aldana, Zebing Liu

Pageof 2

Frequent Collaborators

7 joint publications

Marc Ladanyi

4 joint publications

Elisa de Stanchina

3 joint publications

Marissa S Mattar

3 joint publications

Allan J W Lui